Contrast-Enhanced MR Imaging in Acute Ischemic Stroke: T2* Measures of Blood-Brain Barrier Permeability and Their Relationship to T1 Estimates and Hemorrhagic Transformation

References

1. 1.↵
   1. Kapral MK,
   2. Hall RE,
   3. Silver FL,
   4. et al

   . Registry of the Canadian Stroke Network: Report on the 2004/05 Ontario Stroke Audit. Toronto, Ontario, Canada: Institute for Clinical Evaluative Sciences; 2009
2. 2.↵
   1. Albers GW,
   2. Olivot JM

   . Intravenous alteplase for ischaemic stroke. Lancet 2007;369:249–50

   CrossRefPubMed
3. 3.↵
   1. Hamann GF,
   2. del Zoppo GJ,
   3. von Kummer R

   . Hemorrhagic transformation of cerebral infarction: possible mechanisms. Thromb Haemost 1999;82 (suppl 1):92–94

   PubMed
4. 4.↵
   1. Latour LL,
   2. Kang DW,
   3. Ezzeddine MA,
   4. et al

   . Early blood-brain barrier disruption in human focal brain ischemia. Ann Neurol 2004;56:468–77

   CrossRefPubMedWeb of Science
5. 5.↵
   1. Knight RA,
   2. Barker PB,
   3. Fagan SC,
   4. et al

   . Prediction of impending hemorrhagic transformation in ischemic stroke using magnetic resonance imaging in rats. Stroke 1998;29:144–51

   Abstract/FREE Full Text
6. 6.↵
   1. Ewing JR,
   2. Knight RA,
   3. Nagaraja TN,
   4. et al

   . Patlak plots of Gd-DTPA MRI data yield blood-brain transfer constants concordant with those of 14C-sucrose in areas of blood-brain opening. Magn Reson Med 2003;50:283–92

   CrossRefPubMedWeb of Science
7. 7.↵
   1. Knight RA,
   2. Karki K,
   3. Ewing JR,
   4. et al

   . Estimating blood and brain concentrations and blood-to-brain influx by magnetic resonance imaging with step-down infusion of Gd-DTPA in focal transient cerebral ischemia and confirmation by quantitative autoradiography with Gd-[(14)C]DTPA. J Cereb Blood Flow Metab 2009;29:1048–58. Epub 2009 Mar 25

   CrossRefPubMed
8. 8.↵
   1. Kassner A,
   2. Roberts T,
   3. Taylor K,
   4. et al

   . Prediction of hemorrhage in acute ischemic stroke using permeability MR imaging. AJNR Am J Neuroradiol 2005;26:2213–17

   Abstract/FREE Full Text
9. 9.↵
   1. Kassner A,
   2. Roberts TPL,
   3. Moran B,
   4. et al

   . Recombinant tissue plasminogen activator increases blood-brain barrier disruption in acute ischemic stroke: an MRI permeability study. AJNR Am J Neuroradiol 2009;30:1864–69

   Abstract/FREE Full Text
10. 10.↵
    1. Johnson G,
    2. Wetzel SG,
    3. Cha S,
    4. et al

    . Measuring blood volume and vascular transfer constant from dynamic, T2*-weighted contrast-enhanced MRI. Magn Reson Med 2004;51:961–68

    CrossRefPubMed
11. 11.↵
    1. Lupo JM,
    2. Cha S,
    3. Chang SM,
    4. et al

    . Dynamic susceptibility-weighted perfusion imaging of high-grade gliomas: characterization of spatial heterogeneity. AJNR Am J Neuroradiol 2005;26:1446–54

    Abstract/FREE Full Text
12. 12.↵
    1. Lee MC,
    2. Cha S,
    3. Chang SM,
    4. et al

    . Dynamic susceptibility contrast perfusion imaging of radiation effects in normal-appearing brain tissue: changes in the first-pass and recirculation phases. J Magn Reson Imaging 2005;21:683–93

    CrossRefPubMedWeb of Science
13. 13.↵
    1. Cao Y,
    2. Shen Z,
    3. Chenevert TL,
    4. et al

    . Estimate of vascular permeability and cerebral blood volume using Gd-DTPA contrast enhancement and dynamic T2*-weighted MRI. J Magn Reson Imaging 2006;24:288–96

    CrossRefPubMed
14. 14.↵
    1. Bang OY,
    2. Buck BH,
    3. Saver JL,
    4. et al

    . Prediction of hemorrhagic transformation after recanalization therapy using T2*-permeability magnetic resonance imaging. Ann Neurol 2007;62:170–76

    CrossRefPubMedWeb of Science
15. 15.↵
    1. Bang OY,
    2. Saver JL,
    3. Alger JR,
    4. et al

    . Patterns and predictors of blood-brain barrier permeability derangements in acute ischemic stroke. Stroke 2009;40:454–61

    Abstract/FREE Full Text
16. 16.↵
    1. Wu S-P,
    2. Thornhill RE,
    3. Chen S,
    4. et al

    . Relative recirculation: a fast, model-free surrogate for the measurement of blood-brain barrier permeability and the prediction of hemorrhagic transformation in acute ischemic stroke. Invest Radiol 2009;44:662–68

    CrossRefPubMed
17. 17.↵
    1. Kassner A,
    2. Annesley DJ,
    3. Zhu X-P,
    4. et al

    . Abnormalities of the contrast re-circulation phase in cerebral tumors demonstrated using dynamic susceptibility contrast-enhanced imaging: a possible marker of vascular tortuosity. J Magn Reson Imaging 2000;11:103–13

    CrossRefPubMed
18. 18.↵
    1. Hacke W,
    2. Kaste M,
    3. Fieschi C,
    4. et al

    . Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Lancet 1998;352:1245–51

    CrossRefPubMedWeb of Science
19. 19.↵
    Information for Healthcare Professionals Gadolinium-Based Contrast Agents for Magnetic Resonance Imaging (marketed as Magnevist, MultiHance, Omniscan, OptiMARK, ProHance). US Food and Drug Administration Website. http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm142884.htm. Accessed June 18, 2009.
20. 20.↵
    1. Rosen BR,
    2. Belliveau JW,
    3. Vevea JM,
    4. et al

    . Perfusion imaging with NMR contrast agents. Magn Reson Med 1990;14:249–65

    PubMedWeb of Science
21. 21.↵
    1. Patlak CS,
    2. Blasberg RG,
    3. Fenstermacher JD

    . Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J Cereb Blood Flow Metab 1983;3:1–7

    PubMedWeb of Science
22. 22.↵
    1. Roberts HC,
    2. Roberts TPL,
    3. Brasch RC,
    4. et al

    . Quantitative measurement of microvascular permeability in human brain tumors achieved using dynamic contrast-enhanced MR imaging: correlation with histologic grade. AJNR Am J Neuroradiol 2000;21:891–99

    Abstract/FREE Full Text
23. 23.↵
    1. Jackson A,
    2. Kassner A,
    3. Annesley-Williams D,
    4. et al

    . Abnormalities in the recirculation phase of contrast agent bolus passage in cerebral gliomas: comparison with relative blood volume and tumor grade. AJNR Am J Neuroradiol 2002;23:7–14

    Abstract/FREE Full Text
24. 24.↵
    1. Quarles CC,
    2. Ward BD,
    3. Schmainda KM

    . Improving the reliability of obtaining tumor hemodynamic parameters in the presence of contrast agent extravasation. Magn Reson Med 2005;53:1307–16

    CrossRefPubMedWeb of Science
25. 25.↵
    1. Levin JM,
    2. Kaufman MJ,
    3. Ross MH,
    4. et al

    . Sequential dynamic susceptibility contrast MR experiments in human brain: residual contrast agent effect, steady state, and hemodynamic perturbation. Magn Reson Med 1995;34:655–63

    PubMed
26. 26.↵
    1. Runge VM,
    2. Kirsch JE,
    3. Wells JW,
    4. et al

    . Repeat cerebral blood volume assessment with first-pass MR imaging. J Magn Reson Imaging 1994;4:457–61

    PubMed
27. 27.↵
    1. Wang X,
    2. Lo EH

    . Triggers and mediators of hemorrhagic transformation. Mol Neurobiol 2003;28:229–44

    CrossRefPubMedWeb of Science